<DOC>
	<DOCNO>NCT00313313</DOCNO>
	<brief_summary>The purpose trial understand add saxagliptin sulfonylurea safe work well increase amount sulfonylurea patient take</brief_summary>
	<brief_title>A Study Saxagliptin Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas</brief_title>
	<detailed_description>All subject participate lead-in period , qualify subject continue short-term randomized treatment period . Subjects complete short-term period eligible enter long term extension period . Also , subject short-term period elevate blood sugar require additional medication blood sugar control ( define rescue ) eligible enter long-term treatment extension period receive metformin.Rescue treatment metformin also available long-term extension period subject meet glycemic criterion .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>Type 2 Diabetes . Treated sulfonylurea least 2 month . Inadequate blood sugar control . Are medication low blood sugar . No major heart , liver kidney problem . Women pregnant breast feeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>77 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>